Former FDA commissioner sees hope for stability under new acting leader Kyle Diamantas

At a recent STAT Breakthrough Summit West, former FDA commissioner David Kessler addressed concerns about the agency’s recent turmoil and staff departures.

Kessler said the appointment of acting commissioner Kyle Diamantas, an attorney, could bring needed stability, noting he has confidence that Diamantas understands the FDA’s processes.

While Diamantas lacks a medical background typical of past commissioners, Kessler believes his legal expertise and leadership could help steer the FDA through its current challenges.

The comments reflect optimism that the FDA can regain steadiness, which could be important for the pharmaceutical industry’s regulatory outlook.